Suppr超能文献

相似文献

1
Smad7 is inactivated through a direct physical interaction with the LIM protein Hic-5/ARA55.
Oncogene. 2008 Nov 20;27(54):6791-805. doi: 10.1038/onc.2008.291. Epub 2008 Sep 1.
2
Hic-5 controls BMP4 responses in prostate cancer cells through interacting with Smads 1, 5 and 8.
Oncogene. 2012 May 10;31(19):2480-90. doi: 10.1038/onc.2011.422. Epub 2011 Sep 26.
3
Novel function of androgen receptor-associated protein 55/Hic-5 as a negative regulator of Smad3 signaling.
J Biol Chem. 2005 Feb 18;280(7):5154-62. doi: 10.1074/jbc.M411575200. Epub 2004 Nov 23.
4
Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness.
Oncogene. 2011 Jan 13;30(2):167-77. doi: 10.1038/onc.2010.400. Epub 2010 Sep 6.
5
YAP/TAZ regulates TGF-β/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts.
Cell Commun Signal. 2018 Apr 25;16(1):18. doi: 10.1186/s12964-018-0232-3.
6
TSC-22 promotes transforming growth factor β-mediated cardiac myofibroblast differentiation by antagonizing Smad7 activity.
Mol Cell Biol. 2011 Sep;31(18):3700-9. doi: 10.1128/MCB.05448-11. Epub 2011 Jul 26.
7
8
Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.
J Biol Chem. 2016 Jan 1;291(1):382-92. doi: 10.1074/jbc.M115.694281. Epub 2015 Nov 10.
9
The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.
Oncogene. 1999 Sep 23;18(39):5363-72. doi: 10.1038/sj.onc.1202909.
10

引用本文的文献

1
Scaffold Proteins in Fibrotic Diseases of Visceral Organs.
Biomolecules. 2025 Mar 16;15(3):420. doi: 10.3390/biom15030420.
2
Leupaxin promotes hepatic gluconeogenesis and glucose metabolism by coactivation with hepatic nuclear factor 4α.
Mol Metab. 2025 Jan;91:102075. doi: 10.1016/j.molmet.2024.102075. Epub 2024 Nov 26.
3
Physiological and pathological roles of Hic‑5 in several organs (Review).
Int J Mol Med. 2022 Nov;50(5). doi: 10.3892/ijmm.2022.5194. Epub 2022 Oct 12.
4
Therapeutic Mechanism and Clinical Observation of Traditional Chinese Medicine Combined with Interventional Recanalization for Tubal Infertility.
Evid Based Complement Alternat Med. 2021 Oct 31;2021:2842250. doi: 10.1155/2021/2842250. eCollection 2021.
5
Paxillin family of focal adhesion adaptor proteins and regulation of cancer cell invasion.
Int Rev Cell Mol Biol. 2020;355:1-52. doi: 10.1016/bs.ircmb.2020.05.003. Epub 2020 Aug 6.
6
HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression.
Cell Death Dis. 2019 Nov 18;10(12):873. doi: 10.1038/s41419-019-2114-z.
8
The focal adhesion scaffold protein Hic-5 regulates vimentin organization in fibroblasts.
Mol Biol Cell. 2019 Dec 1;30(25):3037-3056. doi: 10.1091/mbc.E19-08-0442. Epub 2019 Oct 23.
10
TGF-BETA IN THE NATURAL HISTORY OF PROSTATE CANCER.
Acta Clin Croat. 2019 Mar;58(1):128-138. doi: 10.20471/acc.2019.58.01.17.

本文引用的文献

1
Rb/E2F4 and Smad2/3 link survivin to TGF-beta-induced apoptosis and tumor progression.
Oncogene. 2008 Sep 11;27(40):5326-38. doi: 10.1038/onc.2008.165. Epub 2008 May 26.
2
Hic-5 promotes the hypertrophic scar myofibroblast phenotype by regulating the TGF-beta1 autocrine loop.
J Invest Dermatol. 2008 Oct;128(10):2518-25. doi: 10.1038/jid.2008.90. Epub 2008 Apr 10.
4
TGF-beta signaling: a tale of two responses.
J Cell Biochem. 2007 Oct 15;102(3):593-608. doi: 10.1002/jcb.21501.
8
Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells.
Cancer Res. 2006 Jul 15;66(14):7326-33. doi: 10.1158/0008-5472.CAN-05-2379.
9
Oligomerizing potential of a focal adhesion LIM protein Hic-5 organizing a nuclear-cytoplasmic shuttling complex.
J Biol Chem. 2006 Aug 4;281(31):22048-22061. doi: 10.1074/jbc.M513111200. Epub 2006 May 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验